SYBX

SYNLOGIC, INC.

OTC · Pharmaceutical Preparations · Inc. DE · CIK 0001527599
$0.7400 -1.33%
High Impact Filing (7/10)
Vol
Inst. Holders11 funds
Inst. Value$533.5K
Inst. Activity1 buys / 0 sells
SEC Reports2
Exchange OTC·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001527599·Prev Close $0.7500

Recent Activity

Analyst Ratings

Historical distribution0% buy · 6 analysts · last covering-analyst action Mar 2024
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
DateFirmActionRating
Mar 20, 2024 HC Wainwright & Co. UPGRADE Sell → Neutral
Feb 9, 2024 Chardan Capital DOWNGRADE Buy → Neutral
Feb 9, 2024 Leerink Partners DOWNGRADE Outperform → Market Perform
Feb 9, 2024 HC Wainwright & Co. DOWNGRADE Buy → Sell
Dec 11, 2023 Alliance Global Partners INITIATE Buy

Top Institutional Holders

FundValueMove
VANGUARD GROUP INC$225.2K
CITADEL ADVISORS LLC$158.6KTRIM
RENAISSANCE TECHNOLOGIES LLC$95.9KDOUBLED
BlackRock, Inc.$22.1K
SUSQUEHANNA INTERNATIONAL GROUP, LLP$13.0K
11 institutional holders with $533.5K total value (476,337 shares) as of 2025-Q4. Top holders: VANGUARD, CITADEL, RENAISSANCE. Net buying activity: 1 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1VANGUARD GROUP INC201,060$225.2K42.2%
2CITADEL ADVISORS LLC141,608$158.6K29.7%TRIM -43.0%
3RENAISSANCE TECHNOLOGIES LLC85,627$95.9K18.0%DOUBLED +116.7%
4BlackRock, Inc.19,757$22.1K4.1%
5SUSQUEHANNA INTERNATIONAL GROUP, LLP11,623$13.0K2.4%
6STATE STREET CORP10,176$11.4K2.1%
7FMR LLC5,323$6.0K1.1%NEAR_EXIT -96.8%
8MORGAN STANLEY1,095$1.2K0.2%
9BANK OF AMERICA CORP /DE/66$73.000.0%
10CITIGROUP INC1$1.000.0%
11DANSKE BANK A/S1$1.000.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
RENAISSANCE TECHNOLOGIES LLCDOUBLED39,51085,627+116.7%$95.9K2025-Q4
RENAISSANCE TECHNOLOGIES LLCADD23,81039,510+65.9%$65.9K2025-Q3
FMR LLCNEAR_EXIT166,0015,323-96.8%$9.0K2025-Q3
RENAISSANCE TECHNOLOGIES LLCTRIM71,92822,310-69.0%$31.2K2024-Q4
FMR LLCTRIM230,209166,724-27.6%$248.4K2024-Q3
CITADEL ADVISORS LLCTRIM28,85016,449-43.0%$24.5K2024-Q3

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Mar 2024): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
2025-06-30
$0.00 $0.00 $0.00 $0.0B
Current FY
2025-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
4 analyst firms have rated this stock: 1 upgrades, 3 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Mar 20, 2024 HC Wainwright & Co. UPGRADE Sell Neutral
Feb 9, 2024 Chardan Capital DOWNGRADE Buy Neutral
Feb 9, 2024 Leerink Partners DOWNGRADE Outperform Market Perform
Feb 9, 2024 HC Wainwright & Co. DOWNGRADE Buy Sell
Dec 11, 2023 Alliance Global Partners INITIATE Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
May 1, 2025003120%
Apr 1, 2025003120%
Mar 1, 2025003120%
Feb 1, 2025003120%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 6, 2026
earnings_calendar
SYBX Q1 2026 Earnings Scheduled — 2026-05-06
Mar 4, 2026
earnings_calendar
SYBX Q4 2025 Earnings After Market Close — 2026-03-04